Article
Envision Pharma Group
AI in Medical Affairs
Summary
In this episode, Tom Caravela and Patrina Pellett discuss insights from a recent AI in Medical Affairs conference. Tom highlights the lively atmosphere and key AI topics like efficiencies, patient outcomes, and use cases. The conversation covers AI's role in content development, training, predictive analytics, and its impact on medical affairs and the patient journey. They explore AI's potential in rare disease identification and insights analysis, emphasizing the human element and business efficiencies. Key takeaways include the importance of prompt engineering and custom GPTs.
AI in Medical Affairs, patient outcomes, predictive analytics, rare disease identification, prompt engineering
Related Topics
You May Also Like
Envision Pharma Group
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Fierce Pharma Engage 2025 - RECAP
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li